Angion Biomedica

Angion Biomedica

Clinical stage organ restoration biopharmaceutical company focused on renal disease. Learn more

Launch date
Employees
Market cap
$301m
Enterprise valuation
$272m (Public information from Jun 2023)
Hempstead New York (HQ)
Authorizing premium user...